GCM
IDXX icon

Gunderson Capital Management’s Idexx Laboratories IDXX Stock Holding History

Gunderson Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,464
Closed -$4.04M – 40
2019
Q4 		$4.04M Sell
15,464
-236
-2% -$62.2K 4.41% 11
2019
Q3 		$4.27M Sell
15,700
-754
-5% -$210K 4.23% 9
2019
Q2 		$4.53M Buy
+16,454
New +$4.05M 3.97% 7

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Gunderson Capital Management's IDXX Position: Q1 2020 in Review

Gunderson Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 15,464 shares — an estimated $4.04M sold.

Gunderson Capital Management first reported a position in IDXX in Q2 2019 and held it in 3 quarters. The position peaked at $4.53M in Q2 2019. 749 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

  • Gunderson Capital Management reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
  • Gunderson Capital Management sold 15,464 Idexx Laboratories shares in Q1 2020, an estimated $4.04M.
  • Gunderson Capital Management first reported a position in Idexx Laboratories in Q2 2019 and held it in 3 quarters.
  • Gunderson Capital Management's Idexx Laboratories position peaked at $4.53M in Q2 2019.
  • 749 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Gunderson Capital Management's 13F filing for Q1 2020, filed 12 May 2020.